Amgen (AMGN) Current Assets (2016 - 2025)
Historic Current Assets for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $27.9 billion.
- Amgen's Current Assets rose 418.07% to $27.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $27.9 billion, marking a year-over-year increase of 418.07%. This contributed to the annual value of $29.0 billion for FY2024, which is 429.25% down from last year.
- According to the latest figures from Q3 2025, Amgen's Current Assets is $27.9 billion, which was up 418.07% from $26.7 billion recorded in Q2 2025.
- Amgen's Current Assets' 5-year high stood at $48.5 billion during Q3 2023, with a 5-year trough of $18.5 billion in Q1 2022.
- For the 5-year period, Amgen's Current Assets averaged around $28.0 billion, with its median value being $26.8 billion (2024).
- Its Current Assets has fluctuated over the past 5 years, first soared by 14521.27% in 2023, then plummeted by 4478.62% in 2024.
- Over the past 5 years, Amgen's Current Assets (Quarter) stood at $19.4 billion in 2021, then grew by 14.45% to $22.2 billion in 2022, then soared by 36.72% to $30.3 billion in 2023, then decreased by 4.29% to $29.0 billion in 2024, then dropped by 3.94% to $27.9 billion in 2025.
- Its Current Assets stands at $27.9 billion for Q3 2025, versus $26.7 billion for Q2 2025 and $26.9 billion for Q1 2025.